
The new guidelines conclude that current evidence is insufficient to assess the balance of benefits and harms of screening for AF in adults ≥50 years.

The new guidelines conclude that current evidence is insufficient to assess the balance of benefits and harms of screening for AF in adults ≥50 years.

MindMed will now move forward with the 200 patient randomized, placebo-controlled study.

The institute will assemble and support a diverse, multidisciplinary team of scientists and researchers to lead the charge breakthroughs in airway science.

The selective inhibitor therapy is being investigated for the treatment of 2 forms of chronic cough—an indication that's been unmet in 60 years.

Due to costs, it is difficult to screen for and diagnose patients with C difficile infections.

An increase of 57% in new-onset type 1 diabetes admissions was observed from March 2020 - 2021.

Since an effective treatment for the rare disease metachromatic leukodystrophy had not previously been distinguished, investigators analyzed data on the safety and efficacy of arsa-cel, a gene therapy.

Preconception paternal smoking was also not associated with birth weight or paternal BMI.

Early-pregnancy NT-proBNP level may be an important determinant of pregnancy outcomes and CV risk.


Analysis of 2 national surveys suggest a more than two-fold greater likelihood of depressed Americans endorsing a false fact about COVID-19 vaccines than others.

Despite the assumption of vaccine hesitancy among Black people in the US, the present study found rapid reductions in COVID-19 vaccine hesitancy among Black individuals in the US.

Bowel wall thickness and hyperemia in the neo-terminal ileum and bowel wall hyperemia at the ileocolic anastomosis were the only IUS parameters linked to endoscopic recurrence.

Balloon dilation is considered the gold standard in treating the complications associated with Crohn’s disease.

The therapeutic met all secondary endpoints measured at 18 months in patients with hATTR amyloidosis with polyneuropathy, which included statistically significant improvements in neuropathy, and quality of life.

More than 70% of both groups met the primary efficacy outcomes.

The biggest theme identified was patients seeking peer-support and information about CPF symptoms, treatments, diet, experimental therapies, natural remedies, and patients’ apprehension regarding treatments.

Anti-TNF agents often cause various side effects, including inflammation.

Children of mothers with IBD are also more likely to be underdeveloped in height and weight compared to the control group.

Immunomodulators, incomplete vaccination, and non-mRNA vaccination were associated with a higher risk of adverse events for patients with IBD.

While Omicron cases surge, Valentina, Baez-Sosa, MD, speaks on the national blood shortage and the risk it poses to patients with sickle cell disease in particular.

After its approval by the FDA, no new safety findings were reported on weekly dosing of the biologic.

The prevalence of AHT decreased by 6.7% each year during the study period, but the number of patients with AHT who died remained stable.

New data suggest hospitalized patients experience little difference in all-cause outcomes dependent on the busyness of their attending hospitalist.

Maureen Achebe goes into detail about the open label extension of the HOPE trial that evaluated to use of Voxelotor in patients with sickle cell disease and anemia.

Patients with asthma were at increased risk of hospitalization and ICU admission or death, prompting investigators to suggest these patients be considered a priority group for booster COVID-19 vaccines.

Dr. Ivy speaks on promising new therapies and training for sickle cell management during the first blood shortage in the United States in 10 years.

As the year begins, Edward Ivy addresses what's currently happening in the field of sickle cell disease from the impact of the blood shortage to exciting new therapies.

Only 12% of SER-109 treated patients had a recurrence, compared to 40% of the placebo group.

The endomina system can be affixed to various testing standard endoscopies for a bendable therapeutic channel.